The patient subsets of interest described by Johansson et al. (2020) have either a unique germline mutation of Methyl-CpG Binding Domain 4 (MBD4) or UVR damage, a signature seen in iris melanoma due to tumour location [79]. Here, MBD4 is linked to iris melanoma.